Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Thermo Fisher Scientific Inc (NYSE:TMO)

173.42
Delayed Data
As of May 26
 +0.52 / +0.30%
Today’s Change
139.07
Today|||52-Week Range
173.64
+22.91%
Year-to-Date
Empire Life Investments Inc. Buys JELD-WEN Holding Inc, Lowe's Inc, CVS Health Corp, ...
May 26 / GuruFocus News - Paid Partner Content
Thermo Fisher (TMO) to Buy Patheon, Expand in Biopharma
May 16 / Zacks.com - Paid Partner Content
Company News for May 16, 2017
May 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close172.90
Today’s open173.31
Day’s range172.88 - 173.56
Volume683,280
Average volume (3 months)1,661,871
Market cap$67.8B
Dividend yield0.35%
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+3.46%
Earnings growth (this year)+11.50%
Earnings growth (next 5 years)+10.88%
Revenue growth (last year)+7.71%
P/E ratio31.6
Price/Sales3.07
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
DHRDanaher Corp-0.11-0.13%
AAgilent Technologies...+0.21+0.35%
MTDMettler-Toledo Inter...+1.30+0.23%
WATWaters Corp-0.53-0.30%
Data as of 4:03pm ET, 05/26/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$2.26
Annual revenue (last year)$18.3B
Annual profit (last year)$2.0B
Net profit margin11.08%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Marc N. Casper
Chief Financial Officer &
Senior Vice President
Stephen Williamson
Corporate headquarters
Waltham, Massachusetts

Forecasts